Literature DB >> 25912438

Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats.

Dionysia Papagiannopoulou1, Lina Vardouli2, Fotios Dimitriadis2, Apostolos Apostolidis3.   

Abstract

OBJECTIVE: To investigate the potential distribution of radiolabelled botulinum neurotoxin type A (BoNT/A) in the CNS after bladder injection in normal rats, by using the gamma-emitting radionuclide technetium-99 m ((99m) Tc).
MATERIALS AND METHODS: BoNT/A was radiolabelled by pretreatment with 2-iminothiolane and incubation with (99m) Tc-gluconate. The labelled toxin (99m) Tc-BoNT/A was purified using size exclusion HPLC. Twenty-four female Wistar rats were evenly injected in the bladder wall with either (99m) Tc-ΒοΝΤ/Α (n = 12) or free (99m) Tc (n = 12). Four rats from each group were killed at 1, 3 and 6 h after injection, respectively. The bladder, L6-S1 spinal cord segment and L6-S1 dorsal root ganglia (DRG) were harvested and their radioactivity counted in a gamma scintillation detector. Results were calculated as % injected dose (I.D.) per gram of tissue. The paired t-test was used for comparison of means of (99m) Tc-ΒοΝΤ/Α radioactivity vs free (99m) Tc in the tissues of interest.
RESULTS: Radiolabelled BoNT/A had a high radiochemical stability of 70% after 24 h. Gradual accumulation of (99m) Tc-ΒοΝΤ/Α was observed in the DRG up to 6 h after injection (P = 0.04 and P = 0.029 compared with 1 h and 3 h, respectively), while no accumulation was detected for free (99m) Tc. Consequently, (99m) Tc-ΒοΝΤ/Α radioactivity in the DRG was higher than free (99m) Tc radioactivity (3.18 ± 0.67% I.D./g vs 0.19 ± 0.10% I.D./g [P = 0.002] 6 h after injection). Values for (99m) Tc-ΒοΝΤ/Α radioactivity in the spinal cord were higher than those for free (99m) Tc, but not significantly. The bladder retained higher dosages of (99m) Tc-ΒοΝΤ/Α than free (99m) Tc at all time points.
CONCLUSIONS: Significant accumulation of the radiolabelled toxin in the lumbosacral DRG, together with a less significant uptake in the respective spinal cord segment as opposed to free radioactivity provide first evidence of the retrograde transport of BoNT/A to the CNS after bladder injection in rats.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  axonal transport; bladder; botulinum toxin; ganglia; retrograde; spinal cord

Mesh:

Substances:

Year:  2015        PMID: 25912438     DOI: 10.1111/bju.13163

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  15 in total

1.  Intravesical electromotive administration of botulinum toxin type A in improving the bladder and bowel functions: Evidence for novel mechanism of action.

Authors:  Abdol-Mohammad Kajbafzadeh; Hamed Ahmadi; Laleh Montaser-Kouhsari; Shabnam Sabetkish; Sanam Ladi-Seyedian; Masoud Sotoudeh
Journal:  J Spinal Cord Med       Date:  2019-04-18       Impact factor: 1.985

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 3.  Selective Manipulation of Neural Circuits.

Authors:  Hong Geun Park; Jason B Carmel
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 4.  Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2015-06-18       Impact factor: 4.546

Review 5.  Therapeutic use of botulinum toxin in pain treatment.

Authors:  Raj Kumar
Journal:  Neuronal Signal       Date:  2018-08-31

Review 6.  Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer.

Authors:  Karl-Erik Andersson; George Joseph Christ; Kelvin P Davies; Eric S Rovner; Arnold Melman
Journal:  Ther Clin Risk Manag       Date:  2021-06-04       Impact factor: 2.755

7.  Botulinum toxin type A induces changes in the chemical coding of substance P-immunoreactive dorsal root ganglia sensory neurons supplying the porcine urinary bladder.

Authors:  Agnieszka Bossowska; Ewa Lepiarczyk; Urszula Mazur; Paweł Janikiewicz; Włodzimierz Markiewicz
Journal:  Toxins (Basel)       Date:  2015-11-16       Impact factor: 4.546

Review 8.  Botulinum toxin A for the Treatment of Overactive Bladder.

Authors:  Po-Fan Hsieh; Hung-Chieh Chiu; Kuan-Chieh Chen; Chao-Hsiang Chang; Eric Chieh-Lung Chou
Journal:  Toxins (Basel)       Date:  2016-02-29       Impact factor: 4.546

Review 9.  Treatment of painful bladder syndrome/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients?

Authors:  Neil S Lamarre; Dale E Bjorling
Journal:  Transl Androl Urol       Date:  2015-10

Review 10.  The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A.

Authors:  Chung-Cheng Wang; Yung-Hong Jiang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.